E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers S > Headlines for Sangamo Biosciences Inc. > News item
Published on 10/31/2006 in the Prospect News Biotech Daily.

Sangamo corrects net loss per share to $0.08 from $0.09

By Lisa Kerner

Charlotte, N.C., Oct. 31 - Sangamo BioSciences, Inc. corrected its previously announced third-quarter basic and diluted net loss per common to $0.08 from $0.09.

The company said it used incorrect shares in computing the net loss per common share for the quarter ended Sept. 30.

Richmond, Calif.-based Sangamo develops novel DNA-binding proteins for therapeutic gene regulation and modification.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.